COVID: BioNTech to supply new vaccine very soon to neutralise Omicron
The new vaccine is, however, still expected to be more effective in neutralising the variants currently in circulation, the report said.;
Advertisement
Berlin: German biotechnology company BioNTech is planning to start distributing, from early next month, a new Covid-19 vaccine that has been developed to neutralise two Omicron variants.
"We will be able to deliver very soon, hopefully at the beginning of September," BioNTech chief executive Ugur Sahin said, DPA news agency reported, citing Der Spiegel.
The European Medicines Agency (EMA) recently announced that it would decide on applications from BioNTech-Pfizer and Moderna regarding their vaccines adapted for the BA.1 variant of the virus. However, this variant is of declining importance in Europe.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.